Cargando…
Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients
Mucositis and muscle wasting are two common toxicity effects of cancer treatment in head and neck cancer (HNC). There is limited data evaluating cancer treatment toxicities in relation to vitamin status. This study aimed to assess changes in vitamin status during HNC treatment in relation to body co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165496/ https://www.ncbi.nlm.nih.gov/pubmed/30189611 http://dx.doi.org/10.3390/nu10091236 |
_version_ | 1783359851094605824 |
---|---|
author | Nejatinamini, Sara Debenham, Brock J. Clugston, Robin D. Mawani, Asifa Parliament, Matthew Wismer, Wendy V. Mazurak, Vera C. |
author_facet | Nejatinamini, Sara Debenham, Brock J. Clugston, Robin D. Mawani, Asifa Parliament, Matthew Wismer, Wendy V. Mazurak, Vera C. |
author_sort | Nejatinamini, Sara |
collection | PubMed |
description | Mucositis and muscle wasting are two common toxicity effects of cancer treatment in head and neck cancer (HNC). There is limited data evaluating cancer treatment toxicities in relation to vitamin status. This study aimed to assess changes in vitamin status during HNC treatment in relation to body composition, inflammation and mucositis. In this prospective cohort study, dietary intakes (3-day food record), plasma levels of vitamins and C-reactive protein (CRP) were assessed at baseline (at diagnosis) and post-treatment (after 6–8 weeks of radiation therapy with or without chemotherapy). Computed tomography images were used to quantify body composition. Mucositis information was collected from health records of patients. Twenty-eight HNC patients (age 60 ± 10 years) completed both study time points. Patients who developed mucositis had significantly lower dietary intake of vitamins and plasma 25-hydroxy vitamin D (25-OHD) and all-trans retinol levels (p < 0.02). Patients lost a considerable amount of muscle mass (3.4 kg) and fat mass (3.6 kg) over the course of treatment. There was a trend toward greater muscle loss in patients with 25-OHD < 50 nmol/L compared to patients with 25-OHD ≥ 50 nmol/L (p = 0.07). A significant negative correlation was found between plasma all-trans retinol and CRP level at the end of treatment (p = 0.03). Poor vitamin status could be a contributing factor in developing treatment-induced toxicities. |
format | Online Article Text |
id | pubmed-6165496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61654962018-10-10 Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients Nejatinamini, Sara Debenham, Brock J. Clugston, Robin D. Mawani, Asifa Parliament, Matthew Wismer, Wendy V. Mazurak, Vera C. Nutrients Article Mucositis and muscle wasting are two common toxicity effects of cancer treatment in head and neck cancer (HNC). There is limited data evaluating cancer treatment toxicities in relation to vitamin status. This study aimed to assess changes in vitamin status during HNC treatment in relation to body composition, inflammation and mucositis. In this prospective cohort study, dietary intakes (3-day food record), plasma levels of vitamins and C-reactive protein (CRP) were assessed at baseline (at diagnosis) and post-treatment (after 6–8 weeks of radiation therapy with or without chemotherapy). Computed tomography images were used to quantify body composition. Mucositis information was collected from health records of patients. Twenty-eight HNC patients (age 60 ± 10 years) completed both study time points. Patients who developed mucositis had significantly lower dietary intake of vitamins and plasma 25-hydroxy vitamin D (25-OHD) and all-trans retinol levels (p < 0.02). Patients lost a considerable amount of muscle mass (3.4 kg) and fat mass (3.6 kg) over the course of treatment. There was a trend toward greater muscle loss in patients with 25-OHD < 50 nmol/L compared to patients with 25-OHD ≥ 50 nmol/L (p = 0.07). A significant negative correlation was found between plasma all-trans retinol and CRP level at the end of treatment (p = 0.03). Poor vitamin status could be a contributing factor in developing treatment-induced toxicities. MDPI 2018-09-05 /pmc/articles/PMC6165496/ /pubmed/30189611 http://dx.doi.org/10.3390/nu10091236 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nejatinamini, Sara Debenham, Brock J. Clugston, Robin D. Mawani, Asifa Parliament, Matthew Wismer, Wendy V. Mazurak, Vera C. Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title | Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title_full | Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title_fullStr | Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title_full_unstemmed | Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title_short | Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients |
title_sort | poor vitamin status is associated with skeletal muscle loss and mucositis in head and neck cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165496/ https://www.ncbi.nlm.nih.gov/pubmed/30189611 http://dx.doi.org/10.3390/nu10091236 |
work_keys_str_mv | AT nejatinaminisara poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT debenhambrockj poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT clugstonrobind poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT mawaniasifa poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT parliamentmatthew poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT wismerwendyv poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients AT mazurakverac poorvitaminstatusisassociatedwithskeletalmusclelossandmucositisinheadandneckcancerpatients |